AI assistant
INSMED Inc — Director's Dealing 2025
Mar 19, 2025
30150_dirs_2025-03-19_299b7d16-4852-49bc-a676-c87305431d16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-03-17
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-17 | Common Stock | M | 18750 | $22.76 | Acquired | 352936 | Direct |
| 2025-03-17 | Common Stock | S | 4727 | $75.91 | Disposed | 348209 | Direct |
| 2025-03-17 | Common Stock | S | 5907 | $76.87 | Disposed | 342302 | Direct |
| 2025-03-17 | Common Stock | S | 8116 | $77.79 | Disposed | 334186 | Direct |
| 2025-03-17 | Common Stock | M | 6830 | $10.85 | Acquired | 240754 | Indirect |
| 2025-03-17 | Common Stock | S | 2023 | $76 | Disposed | 238731 | Indirect |
| 2025-03-17 | Common Stock | S | 2070 | $77.01 | Disposed | 236661 | Indirect |
| 2025-03-17 | Common Stock | S | 2737 | $77.83 | Disposed | 233924 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-03-17 | Stock Option (right to buy) | $22.76 | M | 18750 | Disposed | 2025-05-21 | Common Stock (18750) | Direct |
| 2025-03-17 | Stock Option (right to buy) | $10.85 | M | 6830 | Disposed | 2026-05-19 | Common Stock (6830) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50500 | Indirect |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 4,727 shares sold at prices ranging from $75.32 to $76.31 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 5,907 shares sold at prices ranging from $76.32 to $77.31 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 8,116 shares sold at prices ranging from $77.34 to $78.06 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 2,023 shares sold at prices ranging from $75.52 to $76.47 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 2,070 shares sold at prices ranging from $76.54 to $77.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: This is the weighted average sales price representing 2,737 shares sold at prices ranging from $77.72 to $77.99 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F8: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.